WebCytarabine also suppressed the development of cell-mediated immune responses such as delayed hypersensitivity skin reaction to dinitrochlorobenzene. However, it had no effect on already established delayed hypersensitivity reactions. Following 5-day courses of intensive therapy with cytarabine the immune response was suppressed, WebMar 21, 2024 · SIDE EFFECTS Expected Reactions. Because cytarabine is a bone marrow suppressant, anemia, leukopenia, thrombocytopenia, megaloblastosis and reduced reticulocytes can be expected as a result of administration with cytarabine.The severity of these reactions are dose and schedule dependent. Cellular changes in the morphology …
Immediate type hypersensitivity to chemotherapeutic agents in …
WebSep 1, 2012 · Uncommon type I HSR to ‘cytarabine’ include dyspnea, chest pain, urticaria, hypotension. Other cytarabine-associated symptoms include subacute, non-immunogenic conjunctivitis and palmar-plantar erythema. Type I HSR to ‘cyclophosphamide and ifosfamide’ occur in <1% of patients [32], with urticaria usually appearing in the first … WebCytarabine also suppressed the development of cell-mediated immune responses such as delayed hypersensitivity skin reaction to dinitrochlorobenzene. However, it had no … chimney attachments
National Center for Biotechnology Information
WebHypersensitivity. Liposomal cytarabine: active meningeal infection. Cautions. Potent bone marrow suppression. ... fever, chills, or unusual cough.A very serious allergic reaction to this drug is unlikely, but get medical help right away if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the ... WebReactions A. IgE-mediated reactions (Gell-Coombs type I) B. Cytotoxic reactions (Gell-Coombs type II) C. Immune complex reactions (Gell-Coombs type III) D. Cell-mediated reactions (Gell-Coombs type IV) E. Miscellaneous syndromes 1. Hypersensitivity vasculitis 2. Drug rash with eosinophilia and systemic symptoms 3. Pulmonary drug … WebCytarabine also suppressed the development of cell-mediated immune responses such as delayed hypersensitivity skin reaction to dinitrochlorobenzene. However, it had no effect on already established delayed hypersensitivity reactions. Following 5-day courses of intensive therapy with cytarabine, the immune response was chimney attic insulation shield